Related Experiment Video

Updated: Aug 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Pneumocystis pneumonia

F J L Robberts1, L J Chalkley, L D Liebowitz

  • 1Department of Medical Microbiology, Tygerberg Hospital, University of Stellenbosch, PO Box 19063, Tygerberg, 7505. lourensr@sun.ac.za

SADJ : Journal of the South African Dental Association = Tydskrif Van Die Suid-Afrikaanse Tandheelkundige Vereniging
|April 5, 2003
PubMed

Insights

Pneumocystis jiroveci pneumonia is a concern for South African AIDS patients. Sulphonamide resistance, linked to gene mutations, may cause treatment failures.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Molecular Epidemiology

Background:

  • Pneumocystis jiroveci pneumonia (PCP) is a significant opportunistic infection in individuals with Acquired Immunodeficiency Syndrome (AIDS).
  • Prophylactic co-trimoxazole is commonly administered to South African AIDS patients with CD4 counts below 200 cells/microliter.
  • Observed treatment and prophylaxis failures suggest the potential emergence of sulphonamide-resistant Pneumocystis jiroveci strains.

Purpose of the Study:

  • To highlight the potential clinical challenge of sulphonamide resistance in Pneumocystis jiroveci in South Africa.
  • To discuss the molecular basis of sulphonamide resistance in Pneumocystis jiroveci.
  • To underscore the utility of strain typing for molecular epidemiology.

Main Methods:

  • Review of existing literature on Pneumocystis jiroveci pneumonia and sulphonamide resistance.
  • Discussion of the genetic mutations associated with sulphonamide resistance (dihydropteroate synthase gene codons 55 and 57).
  • Consideration of the role of molecular epidemiological tools like strain typing.

Main Results:

  • Sulphonamide resistance in Pneumocystis jiroveci is a documented phenomenon globally.
  • Specific point mutations in the dihydropteroate synthase gene are identified as the cause of resistance.
  • The prophylactic use of co-trimoxazole in immunocompromised patients may exert selective pressure for resistant strains.

Conclusions:

  • Sulphonamide-resistant Pneumocystis jiroveci poses a potential threat to effective PCP management in South Africa.
  • Understanding the genetic basis of resistance is crucial for diagnostics and treatment strategies.
  • Molecular strain typing is a valuable method for tracking the epidemiology of resistant strains.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...